BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test

Reuters

Jun 24, 2025

June 24 (Reuters) - Trinity Biotech PLC TRIB.O:

TRINITY BIOTECH SECURES KEY REGULATORY APPROVAL FOR OFFSHORED AND OUTSOURCED MANUFACTURING OF ITS FLAGSHIP RAPID HIV TEST, ACCELERATING STRATEGIC & FINANCIAL PERFORMANCE TRANSFORMATION
TRINITY BIOTECH PLC - TO IMPLEMENT NEXT PHASE OF NEW TRINSCREEN HIV MANUFACTURING MODELIN Q3 2025
TRINITY BIOTECH PLC - RECEIVES WHO APPROVAL FOR OFFSHORED AND OUTSOURCED UPSTREAM MANUFACTURING OF TRINSCREEN HIV TEST

Source text: ID:nGNX7S5Ql5

Further company coverage: TRIB.O

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2545284005"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2545284005\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2545284005?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-24 20:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2545284005","market":"nz","top_or_hot":-1,"title":"BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test</title></head><body><p><span>June 24 (Reuters)</span><span> - </span>Trinity Biotech <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>TRIB.O</span>:</p><ul><li><p>TRINITY BIOTECH SECURES KEY REGULATORY APPROVAL FOR OFFSHORED AND OUTSOURCED MANUFACTURING OF ITS FLAGSHIP RAPID HIV TEST, ACCELERATING STRATEGIC &amp; FINANCIAL PERFORMANCE TRANSFORMATION</p></li><li><p>TRINITY BIOTECH PLC - TO IMPLEMENT NEXT PHASE OF NEW TRINSCREEN HIV MANUFACTURING MODELIN Q3 2025</p></li><li><p>TRINITY BIOTECH PLC - RECEIVES WHO APPROVAL FOR OFFSHORED  AND OUTSOURCED UPSTREAM MANUFACTURING OF TRINSCREEN HIV TEST</p></li></ul><p>Source text: <span>ID:nGNX7S5Ql5</span></p><p>Further company coverage: <span>TRIB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-06-24 20:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv Test</title></head><body><p><span>June 24 (Reuters)</span><span> - </span>Trinity Biotech <a href=\"https://laohu8.com/S/PLC\">PLC</a> <span>TRIB.O</span>:</p><ul><li><p>TRINITY BIOTECH SECURES KEY REGULATORY APPROVAL FOR OFFSHORED AND OUTSOURCED MANUFACTURING OF ITS FLAGSHIP RAPID HIV TEST, ACCELERATING STRATEGIC &amp; FINANCIAL PERFORMANCE TRANSFORMATION</p></li><li><p>TRINITY BIOTECH PLC - TO IMPLEMENT NEXT PHASE OF NEW TRINSCREEN HIV MANUFACTURING MODELIN Q3 2025</p></li><li><p>TRINITY BIOTECH PLC - RECEIVES WHO APPROVAL FOR OFFSHORED  AND OUTSOURCED UPSTREAM MANUFACTURING OF TRINSCREEN HIV TEST</p></li></ul><p>Source text: <span>ID:nGNX7S5Ql5</span></p><p>Further company coverage: <span>TRIB.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TRIB","symbol_name":"Trinity Biotech plc","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250624:nTUA6XGLLY:1","article_id":"2545284005","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2545284005","pubTimestamp":1750767027,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv TestJune 24 (Reuters) - Trinity Biotech PLC TRIB.O:TRINITY BIOTECH SECURES KE","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TRIB":"Trinity Biotech plc","BK4082":"医疗保健设备"},"translate_title":"简介-Trinity Biotech获得监管机构对其旗舰快速Hiv检测的离岸和外包制造的关键批准","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TRIB":0.9},"content_text":"BRIEF-Trinity Biotech Secures Key Regulatory Approval For Offshored And Outsourced Manufacturing Of Its Flagship Rapid Hiv TestJune 24 (Reuters) - Trinity Biotech PLC TRIB.O:TRINITY BIOTECH SECURES KEY REGULATORY APPROVAL FOR OFFSHORED AND OUTSOURCED MANUFACTURING OF ITS FLAGSHIP RAPID HIV TEST, ACCELERATING STRATEGIC & FINANCIAL PERFORMANCE TRANSFORMATIONTRINITY BIOTECH PLC - TO IMPLEMENT NEXT PHASE OF NEW TRINSCREEN HIV MANUFACTURING MODELIN Q3 2025TRINITY BIOTECH PLC - RECEIVES WHO APPROVAL FOR OFFSHORED  AND OUTSOURCED UPSTREAM MANUFACTURING OF TRINSCREEN HIV TESTSource text: ID:nGNX7S5Ql5Further company coverage: TRIB.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory,event","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}